The NK1 receptor antagonist N-acetyl-l-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model

The NK1 receptor antagonist N-acetyl-l-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model

Background: Dyskinesia or abnormal involuntary movements (AIMs) are a disabling effect of chronic l-DOPA administration and consequent pulsatile stimulation of dopamine receptors. This abnormal activation causes maladaptive changes including upregulation of FosB expression in dynorphin containing st...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Thornton, E, Hassall, M, Corrigan, F, Vink, R
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	Elsevier 2014

समान संसाधन

Anti-dyskinetic efficacy of 5-HT3 receptor antagonist in the hemi-parkinsonian rat model
द्वारा: Nazanin Aboulghasemi, और अन्य
प्रकाशित: (2019-06-01)

Levodopa-Induced Dyskinesia Is Associated with Increased Thyrotropin Releasing Hormone in the Dorsal Striatum of Hemi-Parkinsonian Rats
द्वारा: Cantuti-Castelvetri, Ippolita, और अन्य
प्रकाशित: (2011)

Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.
द्वारा: Ippolita Cantuti-Castelvetri, और अन्य
प्रकाशित: (2010-11-01)

In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias
द्वारा: Rosario Sánchez-Pernaute, और अन्य
प्रकाशित: (2007-08-01)

Transplantation of melanocytes obtained from the skin ameliorates apomorphine-induced abnormal behavior in rodent hemi-parkinsonian models.
द्वारा: Masato Asanuma, और अन्य
प्रकाशित: (2013-01-01)

Parkinsonian patients and poor awareness of dyskinesias.
द्वारा: Sara ePietracupa, और अन्य
प्रकाशित: (2014-03-01)

Effect of a selective glutamate antagonist on l-dopa-induced dyskinesias in drug-naive parkinsonian monkeys
द्वारा: Abdallah Hadj Tahar, और अन्य
प्रकाशित: (2004-03-01)

Systematic Evaluation of DBS Parameters in the Hemi-Parkinsonian Rat Model
द्वारा: Soheil Mottaghi, और अन्य
प्रकाशित: (2020-10-01)

The beneficial effect of the flavonoid quercetin on behavioral changes in hemi-Parkinsonian rats
द्वारा: Mehdi Mehdizadeh, और अन्य
प्रकाशित: (2010-01-01)

The beneficial effect of the flavonoid quercetin on behavioral changes in hemi-Parkinsonian rats
द्वारा: Mehdi Mehdizadeh, और अन्य
प्रकाशित: (2010-01-01)

7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate
द्वारा: M. T. Herrero, और अन्य
प्रकाशित: (2023-05-01)

Neuroanatomical and Microglial Alterations in the Striatum of Levodopa-Treated, Dyskinetic Hemi-Parkinsonian Rats
द्वारा: Edward J. R. Fletcher, और अन्य
प्रकाशित: (2020-09-01)

Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice
द्वारा: Ziqing Shi, और अन्य
प्रकाशित: (2020-11-01)

Synergistic Effects of Adenosine A2A Antagonist and L-DOPA on Rotational Behaviors in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Mouse Model
द्वारा: Takahiro Matsuya, और अन्य
प्रकाशित: (2007-01-01)

Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys
द्वारा: Marc Morissette, और अन्य
प्रकाशित: (2022-02-01)

A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys
द्वारा: Daniella Rylander, और अन्य
प्रकाशित: (2010-09-01)

IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primates.
द्वारा: Romina Aron Badin, और अन्य
प्रकाशित: (2013-01-01)

Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson′s disease
द्वारा: Emma Thornton, और अन्य
प्रकाशित: (2015-01-01)

CCK-8S inhibits L-dopa-induced dyskinesias in parkinsonian squirrel monkeys.
द्वारा: Boyce, S, और अन्य
प्रकाशित: (1990)

Potential efficacy of nanocurcumin on levodopa-induced dyskinesia in a rat parkinsonian model
द्वारा: Pegah Ashrafi, और अन्य
प्रकाशित: (2022-11-01)

NK1 antagonists attenuate tau phosphorylation after blast and repeated concussive injury
द्वारा: Frances Corrigan, और अन्य
प्रकाशित: (2021-04-01)

Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates
प्रकाशित: (2013-01-01)

Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates.
द्वारा: Romina Aron Badin, और अन्य
प्रकाशित: (2013-01-01)

The adenosine A2A receptor antagonist/inverse agonist, KW-6356 enhances the anti-parkinsonian activity of L-DOPA with a low risk of dyskinesia in MPTP-treated common marmosets
द्वारा: Yutaro Ohno, और अन्य
प्रकाशित: (2023-07-01)

Treatment with a substance P receptor antagonist is neuroprotective in the intrastriatal 6-hydroxydopamine model of early Parkinson's disease.
द्वारा: Emma Thornton, और अन्य
प्रकाशित: (2012-01-01)

Advancing age and the rs6265 BDNF SNP are permissive to graft-induced dyskinesias in parkinsonian rats
द्वारा: Natosha M. Mercado, और अन्य
प्रकाशित: (2024-08-01)

Intensive Rehabilitation Treatment in Parkinsonian Patients with Dyskinesias: A Preliminary Study with 6-Month Followup
द्वारा: Giuseppe Frazzitta, और अन्य
प्रकाशित: (2012-01-01)

Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats
द्वारा: Stefania eSgroi, और अन्य
प्रकाशित: (2014-10-01)

Chronic Nasal Administration of Kisspeptin-54 Regulates Mood-Related Disorders Via Amygdaloid GABA in Hemi-Parkinsonian Rats
द्वारा: Osman Sinen, और अन्य
प्रकाशित: (2024-11-01)

Molecular Insights into the Interaction of Tryptophan Metabolites with the Human Aryl Hydrocarbon Receptor in Silico: Tryptophan as Antagonist and no Direct Involvement of Kynurenine
द्वारा: Abdulla A-B Badawy, और अन्य
प्रकाशित: (2024-09-01)

NK1-r Antagonist Treatment Comparable to Decompressive Craniectomy in Reducing Intracranial Pressure Following Stroke
द्वारा: Annabel J. Sorby-Adams, और अन्य
प्रकाशित: (2019-07-01)

Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors.
द्वारा: Elizabeth Harford-Wright, और अन्य
प्रकाशित: (2014-01-01)

NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury.
द्वारा: Anna Victoria Leonard, और अन्य
प्रकाशित: (2014-01-01)

The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study.
द्वारा: Cristina Miguelez, और अन्य
प्रकाशित: (2011-01-01)

AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys
द्वारा: Mélanie Bourque, और अन्य
प्रकाशित: (2022-11-01)

Kinin Receptor Antagonists as Potential Neuroprotective Agents in Central Nervous System Injury
द्वारा: Anna V Leonard, और अन्य
प्रकाशित: (2010-09-01)

Dynamic Involvement of Striatal NG2-glia in L-DOPA Induced Dyskinesia in Parkinsonian Rats: Effects of Doxycycline
द्वारा: G.C. Nascimento, और अन्य
प्रकाशित: (2023-03-01)

A Meta-Analysis of Adenosine A2A Receptor Antagonists on Levodopa-Induced Dyskinesia In Vivo
द्वारा: Wen-Wen Wang, और अन्य
प्रकाशित: (2017-12-01)

Dopaminergic-like neurons derived from oral mucosa stem cells by developmental cues improve symptoms in the hemi-parkinsonian rat model.
द्वारा: Javier Ganz, और अन्य
प्रकाशित: (2014-01-01)

The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation
द्वारा: Uros Velickovic, और अन्य
प्रकाशित: (2025-02-01)